BR112021019589A2 - Derivados de isocromenos como inibidores de fosfoinositídeo 3-cinases - Google Patents

Derivados de isocromenos como inibidores de fosfoinositídeo 3-cinases

Info

Publication number
BR112021019589A2
BR112021019589A2 BR112021019589A BR112021019589A BR112021019589A2 BR 112021019589 A2 BR112021019589 A2 BR 112021019589A2 BR 112021019589 A BR112021019589 A BR 112021019589A BR 112021019589 A BR112021019589 A BR 112021019589A BR 112021019589 A2 BR112021019589 A2 BR 112021019589A2
Authority
BR
Brazil
Prior art keywords
kinases
phosphoinositide
inhibitors
isochromene
derivatives
Prior art date
Application number
BR112021019589A
Other languages
English (en)
Portuguese (pt)
Inventor
Claudio Fiorelli
Matteo Biagetti
Paolo Bruno
Paolo Ronchi
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of BR112021019589A2 publication Critical patent/BR112021019589A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
BR112021019589A 2019-04-04 2020-03-24 Derivados de isocromenos como inibidores de fosfoinositídeo 3-cinases BR112021019589A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19167245 2019-04-04
PCT/EP2020/058168 WO2020200918A1 (en) 2019-04-04 2020-03-24 Isochromene derivatives as phosphoinositide 3-kinases inhibitors

Publications (1)

Publication Number Publication Date
BR112021019589A2 true BR112021019589A2 (pt) 2021-12-07

Family

ID=66092138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021019589A BR112021019589A2 (pt) 2019-04-04 2020-03-24 Derivados de isocromenos como inibidores de fosfoinositídeo 3-cinases

Country Status (26)

Country Link
US (1) US12527797B2 (cg-RX-API-DMAC7.html)
EP (1) EP3947384B1 (cg-RX-API-DMAC7.html)
JP (1) JP2022526973A (cg-RX-API-DMAC7.html)
KR (1) KR20210149077A (cg-RX-API-DMAC7.html)
CN (1) CN113874376A (cg-RX-API-DMAC7.html)
AR (1) AR118588A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020252904A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021019589A2 (cg-RX-API-DMAC7.html)
CA (1) CA3135309A1 (cg-RX-API-DMAC7.html)
DK (1) DK3947384T3 (cg-RX-API-DMAC7.html)
ES (1) ES2970530T3 (cg-RX-API-DMAC7.html)
FI (1) FI3947384T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20240130T1 (cg-RX-API-DMAC7.html)
HU (1) HUE065052T2 (cg-RX-API-DMAC7.html)
IL (1) IL286937A (cg-RX-API-DMAC7.html)
MA (1) MA55479A (cg-RX-API-DMAC7.html)
MX (1) MX2021011979A (cg-RX-API-DMAC7.html)
MY (1) MY206575A (cg-RX-API-DMAC7.html)
PH (1) PH12021552402A1 (cg-RX-API-DMAC7.html)
PL (1) PL3947384T3 (cg-RX-API-DMAC7.html)
PT (1) PT3947384T (cg-RX-API-DMAC7.html)
SG (1) SG11202110801XA (cg-RX-API-DMAC7.html)
SI (1) SI3947384T1 (cg-RX-API-DMAC7.html)
TW (1) TW202102504A (cg-RX-API-DMAC7.html)
WO (1) WO2020200918A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202107710B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024180207A1 (en) 2023-03-02 2024-09-06 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
PT1158958E (pt) 1999-03-05 2007-08-13 Chiesi Farma Spa ''composições farmacêuticas em pó, melhoradas, para inalação''
LT2496567T (lt) 2009-11-05 2017-11-27 Rhizen Pharmaceuticals S.A. Nauji benzopirano kinazės moduliatoriai
TWI672297B (zh) 2013-12-18 2019-09-21 義大利商吉斯藥品公司 作為磷脂肌醇-3-激酶抑制劑之異唏衍生物
ES2750791T3 (es) 2014-06-17 2020-03-27 Chiesi Farm Spa Derivados de indolizina como inhibidores de fosfoinositido 3-quinasas
US9745308B2 (en) 2014-09-12 2017-08-29 Chiesi Farmaceutici S.P.A. Pyridazinone derivatives as phoshoinositide 3-kinases inhibitors
US9968604B2 (en) 2015-04-16 2018-05-15 Chiesi Farmaceutici S.P.A. Chromene derivatives as phoshoinositide 3-kinases inhibitors
WO2017134053A1 (en) 2016-02-04 2017-08-10 Chiesi Farmaceutici S.P.A. Pyrazole derivatives as phosphoinositide 3-kinases inhibitors

Also Published As

Publication number Publication date
ES2970530T3 (es) 2024-05-29
CA3135309A1 (en) 2020-10-08
MX2021011979A (es) 2021-11-03
HRP20240130T1 (hr) 2024-04-12
AU2020252904A1 (en) 2021-11-18
SG11202110801XA (en) 2021-10-28
AR118588A1 (es) 2021-10-20
ZA202107710B (en) 2025-03-26
JP2022526973A (ja) 2022-05-27
HUE065052T2 (hu) 2024-04-28
PH12021552402A1 (en) 2022-06-20
DK3947384T3 (da) 2024-01-08
EP3947384A1 (en) 2022-02-09
MY206575A (en) 2024-12-24
CN113874376A (zh) 2021-12-31
EP3947384B1 (en) 2023-11-01
WO2020200918A1 (en) 2020-10-08
FI3947384T3 (fi) 2024-01-30
US20220175784A1 (en) 2022-06-09
US12527797B2 (en) 2026-01-20
MA55479A (fr) 2022-02-09
PT3947384T (pt) 2024-01-29
IL286937A (en) 2021-10-31
SI3947384T1 (sl) 2024-03-29
KR20210149077A (ko) 2021-12-08
PL3947384T3 (pl) 2024-03-25
TW202102504A (zh) 2021-01-16

Similar Documents

Publication Publication Date Title
MX2017016344A (es) Compuestos de benzoxacepina oxazolidinona y metodos de uso.
BR112015028501A2 (pt) derivados de bipirazol como inibidores de jak
DOP2019000005A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
MX2019015431A (es) Compuesto cíclico tipo cumarina como inhibidor de mek y su uso.
BR112015026023A2 (pt) derivados de 2- aminopirido[4,3-d]pirimidin-5-ona e seu uso como inibidores de wee-1
BR112018076169A2 (pt) derivados azabenzimidazol como inibidores de pi3k beta
BR112015016793A2 (pt) compostos de tiazolacarboxamidas e piridinacarbo-xamida úteis como inibidores de quinase pim
BR112016015983A2 (pt) Compostos de indazol como inibidores de irak4, seus usos, e composição farmacêutica
BR112017003433A2 (pt) inibidores espirocíclicos de catepsina c
BR112013021638A2 (pt) "compostos inibidores de trk, seu uso e composições que os compreendem"
BR112015028879A8 (pt) compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos
BR112016006388A2 (pt) inibidor seletivo da fosfatidilinositol 3-quinase gama
BR112016028845A2 (pt) composto, composição farmacêutica e uso de um composto
PH12016501160A1 (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
CL2021001656A1 (es) Compuestos de imidazopiridina e imidazopiridina y sus usos.
BR112017009012A2 (pt) derivados de anel benzo de seis membros como inibidor de dpp-4 e seu uso
GT201700220A (es) Derivados de pirazol útiles como inhibidores de proteína activadora de 5-lipoxigenasa (flap)
MX2017013137A (es) Derivados de cromeno como inhibidores de las fosfoinositido-3-cina sas.
DOP2015000214A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
DOP2019000221A (es) Derivados de pirazol como inhibidores de bromodominio
BR112018007720A2 (pt) novos derivados de piridona e seu uso como inibidores da quinase
BR112017003227A2 (pt) composto, composição farmacêutica e uso de um composto
ZA202107710B (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
PE20240358A1 (es) Derivados de tetrahidrotieno piridina como inhibidores de ddr
AR117459A1 (es) Imidazopiridina y compuestos de imidazopiridazina y usos de los mismos

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements